On-line continuous hemodiafiltration in sepsis

Transfusion and Apheresis Science

Volumn 35, Issue 3, 2006, Pages 265-269

  Kawanishi, Hideki ^a  

^a TSUCHIYA GENERAL HOSPITAL   (Japan)

Author keywords

Continuous hemodiafiltration; Continuous renal replacement therapy; On line hemodiafiltration; Sepsis

Indexed keywords

CD14 ANTIGEN; CYTOKINE; DIALYSIS FLUID; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MAGNESIUM;

ACUTE KIDNEY FAILURE; ARTICLE; BLOOD FLOW; CONTINUOUS RENAL REPLACEMENT THERAPY; DIALYSATE; DIALYSIS; FLUID THERAPY; GLOMERULUS FILTRATION RATE; GRAM NEGATIVE BACTERIUM; HEMODIAFILTRATION; HEMODIALYSIS; HUMAN; INTENSIVE CARE; KIDNEY CLEARANCE; KIDNEY FUNCTION; MULTIPLE ORGAN FAILURE; ONLINE SYSTEM; PRESCRIPTION; PURIFICATION; SEPSIS; SEPTIC SHOCK; SURVIVAL RATE;

CRITICAL CARE; DIALYSIS SOLUTIONS; HEMODIAFILTRATION; HUMANS; SEPSIS; TREATMENT OUTCOME;

EID: 33751538580     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2006.06.005     Document Type: Article

References (25)

1. Hirasawa H., Sugai T., Ohtake Y., Oda S., Matsuda K., and Kitamura N. Blood purification for prevention and treatment of multiple organ failure. World J Surg 20 (1996) 482-486
2. Oda S., Hirasawa H., Shiga H., Nakanishi K., Matsuda K., and Nakamura M. Continuous hemofiltration/hemodiafiltration in critical care. Theory Aph 6 (2002) 193-198
3. Wang Y., Liu Y., Ito Y., Hashiguchi T., Kitajima I., Yamakuchi M., et al. Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymyxin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock. Anal Biochem 294 (2001) 73-82
4. Wang Y., Liu Y., Sarker K.P., Nakashima M., Serizawa T., Kishida A., et al. Polymyxin B binds to anandamide and inhibits its cytotoxic effect. FEBS Lett 470 (2000) 151-155
5. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285 (1999) 248-251
6. Hasunuma R., Maruyama H., Takimoto H., Ryll R., Tanaka S., and Kumazawa Y. Does high mobility group 1 protein function as a late mediator for LPS- or TNF-induced shock in galactosamine-sensitized mice?. J Endotoxin Res 8 (2002) 391-398
7. Hatada T., Wada H., Nobori T., Okabayashi K., Maruyama K., Abe Y., et al. Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation. Thromb Haemostasis 94 (2005) 975-979
8. Henderson L.W., Sanfelippo M.L., and Beans E. 'On-line' preparation of sterile pyrogen-free electrolyte solution. T Am Soc Art Int Org 24 (1978) 465-467
9. Shaldon S., Deschodt G., Granolleras C., et al. •F Experience with on-line hemofiltration. Prog Artif Organs 1 (1983) 586-589
10. Canaud B., Bosc J.Y., Leray H., Stec F., Argiles A., Leblanc M., et al. On-line haemodiafiltration: state of the art. Nephrol Dial Transpl 13 Suppl 5 (1998) 3-11
11. Ledebo I. On-line hemodiafiltration: technique and therapy. Adv Renal Replace Th 6 2 (1999) 195-208
12. Ledebo I., and Nystrand R. Defining the microbiological quality of dialysis fluid. Artif Organs 23 (1999) 37-43
13. Sato T., and Koga N. Centralized on-line hemodiafiltration system utilizing purified dialysate as substitution fluid. Artif Organs 22 (1998) 285-290
14. Gotch FA. Kinetic modeling in peritoneal dialysis, In: Nissenson AR et al. editors., Clinical dialysis. East Noewalk: Appleton & Lange; 1995. pp. 156-188.
15. Clark W.R., Mueller B.A., Kraus M.A., and Macias W.L. Extracorporeal therapy requirements for patients with acute renal failure. J Am Soc Nephrol 8 (1997) 804-812
16. Clark W.R., Mueller B.A., Alaka K.J., and Macias W.L. A comparison of metabolic control by continuous and intermittent therapies in acute renal failure. J Am Soc Nephrol 4 (1994) 1413-1420
17. Marshall M.R., Golper T.A., Shaver M.J., Alam M.G., and Chatoth D.K. Urea kinetics during sustained low-efficiency dialysis in critically ill patients requiring renal replacement therapy. Am J Kidney Dis 39 (2002) 556-570
18. Casino F.G., and Lopez T. The equivalent renal urea clearance: a new parameter to assess dialysis dose. Nephrol Dial Transpl 11 (1996) 1574-1581
19. Luyckx V.A., and Bonventre J.V. Dose of dialysis in acute renal failure. Semin Dialysis 17 (2004) 30-36
20. Clark W., and Ronco C. Renal replacement therapy in acute renal failure : solute removal mechanism and dose quantification. Kidney Int 53 Suppl. 66 (1998) S133-S137
21. Hoffmann J.A., Kafatos F.C., Janeway C.A., and Ezekowitz R.A. Phylogenetic perspectives in innate immunity. Science 284 (1999) 1313-1318
22. Lien E., Means T.K., Heine H., Yoshimura A., Kusumoto S., Fukase K., et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 105 4 Feb (2000) 497-504
23. Varga K., Wagner J.A., Bridgen D.T., and Kunos G. Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J 12 (1998) 1035-1044
24. Cole L., Bellomo R., Journois D., Davenport P., Baldwin I., and Tipping P. High-volume haemofiltration in human septic shock. Intens Care Med 27 (2001) 978-986
25. Ronco C., Bellomo R., Homel P., et al. Effects of different dose in continuous veno-venous haemofiltration on outcomes of acute renal failure: prospective randomized trial. Lancet 356 (2000) 26-30